Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 408-413 , December 2009

Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: Dose-limiting toxicity in apical tumor sites

  • Jeffrey A. Forquer

      Affiliations

    • Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, USA
    • ,
  • Achilles J. Fakiris

      Affiliations

    • Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Indiana University School of Medicine, 535 Barnhill Dr (RT041), Indianapolis, IN 46202, United States.
    • ,
  • Robert D. Timmerman

      Affiliations

    • Department of Radiation Oncology, UT Southwestern School of Medicine, Dallas, USA
    • ,
  • Simon S. Lo

      Affiliations

    • Department of Radiation Oncology, The Ohio State University, Columbus, USA
    • ,
  • Susan M. Perkins

      Affiliations

    • Division of Biostatistics, Indiana University School of Medicine, Indianapolis, USA
    • ,
  • Ronald C. McGarry

      Affiliations

    • Department of Radiation Medicine University of Kentucky, Lexington, USA
    • ,
  • Peter A.S. Johnstone

      Affiliations

    • Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, USA

Received 11 December 2008 ,Revised 13 April 2009 ,Accepted 15 April 2009.

References 

  1. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63:1010–1015
  2. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124:1946–1955
  3. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
  4. Henderson M, McGarry R, Yiannoutsos C, et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;
  5. Sinha B, McGarry RC. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int J Radiat Oncol Biol Phys. 2006;66:1120–1124
  6. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version3.0, DCTD, NCI, NIH, DHHS, March 31, 2003 (http://ctep.cancer.gov), Publish date; August 9 2006.
  7. Radiation Therapy Oncology Group: RTOG0236: a phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the treatment of patients with medically inoperable stage i/ii non-small cell lung cancer. Available from: <http://www.rtog.org/members/protocols/0236/0236.pdf/>.
  8. Hall EJ. Radiobiology for the radiologist. Philadelphia, PA: Lippincott Williams and Wilkins; 2000.
  9. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  10. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847–852
  11. Shaw EG, Gunderson LL, Martin JK, Beart RW, Nagorney DM, Podratz KC. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose–response analysis. Radiother Oncol. 1990;18:247–255
  12. Swartz MH. In: Textbook of physical diagnosis: history and examination. Philadelphia: W.B. Saunders Company; 2002;
  13. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787–795
  14. Beitler JJ, Badine EA, El-Sayah D, et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys. 2006;65:100–106
  15. Fritz P, Kraus HJ, Muhlnickel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol. 2006;1:30
  16. Fukumoto S, Shirato H, Shimzu S, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer. 2002;95:1546–1553
  17. Hiraoka M, Nagata Y. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience. Int J Clin Oncol. 2004;9:352–355
  18. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–1431
  19. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623–1631
  20. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer. 1998;82:1062–1070
  21. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60:186–196
  22. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66:117–125
  23. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer. 2005;48:107–114
  24. Bajrovic A, Rades D, Fehlauer F, et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?. Radiother Oncol. 2004;71:297–301
  25. Olsen NK, Pfeiffer P, Johannsen L, Schroder H, Rose C. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys. 1993;26:43–49
  26. Uematsu M, Bornstein BA, Recht A, et al. Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I–III breast cancer. Int J Radiat Oncol Biol Phys. 1993;25:765–770
  27. Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23:915–923
  28. Salner AL, Botnick LE, Herzog AG, et al. Reversible brachial plexopathy following primary radiation therapy for breast cancer. Cancer Treat Rep. 1981;65:797–802
  29. Kori SH, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer: 100 cases. Neurology. 1981;31:45–50
  30. Ballo MT, Strom EA, Zagars GK, et al. Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys. 2002;52:964–972
  31. Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–1107
  32. Wallace HJ, Willett CG, Shellito PC, Coen JJ, Hoover HC. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. J Surg Oncol. 1995;60:122–127
  33. Johnstone PAS, Wasserman EM, O’Connell PG, DeLaney TF. Lumbosacral plexopathy secondary to hyperfractionated radiation therapy: a case presentation and literature review. Radiat Oncol Invest. 1993;1:126–130
  34. Hall WH, Guiou M, Lee NY, et al. Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2008;

PII: S0167-8140(09)00193-5

doi: 10.1016/j.radonc.2009.04.018

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 408-413 , December 2009

Article Tools

* Image Usage & Resolution